There has been an episode today in our dialysis unit. There was this patient who has gone through an MHD session two days back. We've the policy of applying tourniquet after removing the needle on a tightly rolled gauze piece. But today morning she came back that the bleeding hasn't stopped even today after two days. What could be the reason that after removing fistula needle after even two days the bleeding hasn't stopped.
Reading Document
Medical Text Search
prolonged bleeding after AV fistula needle removal hemodialysis
Medical Text Search
causes of bleeding diathesis in chronic kidney disease hemodialysis patients
GradeResponse
GradeResponse
Medical Text Search
uremic platelet dysfunction coagulopathy hemodialysis bleeding time
Medical Text Search
central vein stenosis AV access venous hypertension prolonged bleeding hemodialysis
Here is a structured, comprehensive analysis of why this MHD patient is still bleeding 48 hours after fistula needle removal.
Prolonged Post-Needling Bleeding in a Hemodialysis Patient — Causes & Approach
This is a clinically important problem. Normal hemostasis at an AV fistula site should be achieved within 5–10 minutes with proper compression. Bleeding persisting for 48 hours is pathological and points to one or more of the following categories:
1. Uremic Platelet Dysfunction (Most Common Underlying Cause)
CKD/ESRD patients have a well-characterized qualitative platelet defect (not a quantitative one):
| Mechanism | Consequence |
|---|---|
| Accumulation of uremic toxins (guanidinosuccinic acid, phenolic acids) | Impaired platelet aggregation and adhesion |
| Reduced platelet TXA₂ synthesis | Decreased primary hemostasis |
| Abnormal GPIb–vWF interaction | Poor platelet-vessel wall adhesion |
| Anemia (low Hct) | Reduced platelet marginalization to vessel wall — Hematocrit < 30% significantly worsens bleeding time |
| Elevated NO and prostacyclin | Further platelet inhibition |
Key point: Even after a "routine" MHD session, uremic toxins reaccumulate rapidly. If the patient's residual renal function is negligible and the session was suboptimal (low Kt/V), platelet dysfunction worsens.
2. Heparin Effect / Anticoagulation Carryover
- Standard MHD uses unfractionated heparin (UFH) or LMWH during the session.
- If the heparin dose was excessive, or if the patient has renal clearance of LMWH impaired (as in ESRD), residual anticoagulant effect can persist well beyond the session.
- LMWH (e.g., enoxaparin) has a prolonged half-life in ESRD — can last 12–24+ hours.
- Was the patient on any antiplatelet agents (aspirin, clopidogrel) or anticoagulants (warfarin, DOACs)? These compound the problem significantly.
3. Central Vein Stenosis (CVS) / Venous Outflow Obstruction (Structural/Access Problem)
As noted in Vascular Access (p. 129):
"Stenotic lesions can lead to clinical signs and symptoms such as prolonged bleeding after removal of the dialysis cannulas and/or elevated venous pressures during routine monitoring with high AV access recirculation."
CVS or outflow stenosis leads to:
- Elevated venous pressures in the access circuit
- Impaired venous return → increased intraluminal pressure at the puncture site
- High-pressure bleeding that overwhelms local compression
Clues to look for: ipsilateral arm edema, breast edema, collateral vein development, elevated venous pressure alarm readings during sessions, high recirculation rates.
4. Inadequate or Incorrect Compression Technique
Your unit's policy — tourniquet on tightly rolled gauze — if applied too loosely or in the wrong anatomical position, will not achieve adequate transmural compression of the puncture site. However, since the history is that it was applied per policy, the issue is more likely systemic (see above).
- Tourniquet alone compresses venous outflow but does not compress the arterial inflow to the fistula — this is a common error. Direct digital or pad compression over the puncture hole is needed simultaneously.
- If the gauze roll was not placed directly over the needle hole but slightly offset, hemostasis will fail.
5. Thrombocytopenia
- Heparin-induced thrombocytopenia (HIT) — occurs typically 5–14 days after starting heparin; causes paradoxical thrombosis but also thrombocytopenia and bleeding at vascular access sites.
- CKD-associated thrombocytopenia — though less common, some MHD patients develop thrombocytopenia from hypersplenism, folate deficiency, or bone marrow suppression.
- A platelet count < 50,000 will impair hemostasis at any puncture site.
6. Pseudo-aneurysm Formation at the Puncture Site
- Repeated needling of the same site (rope-ladder vs. buttonhole vs. area puncture technique) can cause aneurysmal dilation of the fistula wall.
- A pseudoaneurysm with a thin wall will not seal properly after needle removal and may bleed persistently or even rupture.
- Look for: pulsatile swelling, skin thinning over the site, or bruit change.
7. Infection at the Puncture Site
- Local soft tissue infection or cellulitis impairs normal hemostatic clot formation.
- This is particularly relevant for buttonhole technique users, where repeated use of the same tract creates a channel that can harbor organisms.
8. Systemic Coagulation Factor Deficiency
Less common but must consider:
- Vitamin K deficiency (poor oral intake, antibiotic use) → low Factors II, VII, IX, X
- Liver disease comorbidity → impaired synthesis of all clotting factors
- Acquired Factor XIII deficiency — clot forms but is not cross-linked, leading to clot dissolution and rebleeding
Immediate Workup to Order
| Investigation | What it tells you |
|---|---|
| CBC with platelet count | Thrombocytopenia |
| PT/INR, aPTT | Coagulation factor deficiency, heparin effect |
| Bleeding time / PFA-100 | Platelet function (uremia effect) |
| Anti-Xa level (if LMWH used) | Residual LMWH activity |
| Serum heparin / HIT antibody | HIT if clinically suspected |
| Fistula duplex ultrasound | CVS, stenosis, pseudoaneurysm, venous pressures |
| BUN/creatinine, Kt/V | Adequacy of dialysis / uremic burden |
| Hemoglobin/Hematocrit | Anemia worsening platelet–vessel interaction |
Management Approach
- Immediate: Direct firm compression for 15–20 min; do not rely on tourniquet alone.
- Correct anemia: Target Hct > 30% — this alone significantly shortens bleeding time in uremia.
- Desmopressin (DDAVP) 0.3 mcg/kg IV/SC: Releases vWF from endothelial stores — works within 1–2 hours, useful for acute uremic bleeding.
- Cryoprecipitate: Contains vWF and Factor VIII — for refractory cases.
- Conjugated estrogens: For longer-term platelet dysfunction management.
- Reverse anticoagulation if heparin overload is suspected (protamine sulfate for UFH; consider if LMWH excess is causing problem).
- Vascular surgery/interventional radiology referral: If CVS or pseudoaneurysm is found on duplex.
- Review needling technique and site rotation.
Summary
The most likely combination in your patient is:
- Uremic platelet dysfunction (the baseline problem in every MHD patient)
- Compounded by residual heparin effect, anemia, and possibly venous outflow stenosis explaining why standard post-needle compression failed for 48 hours.
The central vein stenosis cause is particularly important not to miss — it is a structural problem that will recur with every session until addressed interventionally.
This is a shared conversation. Sign in to Orris to start your own chat.